Aptevo Therapeutics (United Kingdom)

Recent papers from Aptevo Therapeutics (United Kingdom)

1. Targeting ZIP12-mediated Zn 2+ signaling as a treatment for pulmonary hypertensionScience Translational Medicine · 2026
2. Self‐Assembled Aptamer‐Derived PROTAC Enables Efficient Cellular Internalization for Intracellular Sclerostin Degradation and Triple‐Negative Breast Cancer TherapyAdvanced Healthcare Materials · 2026
3. An Accountability-First Framework for Organisational AI Governance: Addressing the Structural Limits of Compliance-First Instruments2026
4. The Responsible AI Divide: Adoption Without Accountability in African Digital Economies2026
5. Intelligence at the Edge: Design Requirements for Accountable AI in Retail and Algorithmic Trading Under the UK and EU Regimes2026
6. Black Box and Beyond: Auditing Large Language Models, AI Agents, and AI Infrastructure Under the UK and EU Regulatory Frameworks2026
7. Population pharmacokinetics and pharmacodynamics of canagliflozin in paediatric patients with type 2 diabetes mellitusBritish Journal of Clinical Pharmacology · 2026
8. Robust human genetic evidence supporting causal effects of FGF21 on reducing alcohol consuming behavioursBMC Medicine · 2026
9. Population Pharmacokinetic and Exposure‐Response Analyses of Ibrutinib Combined With Bendamustine and Rituximab in Patients With Mantle Cell LymphomaCPT Pharmacometrics & Systems Pharmacology · 2025
10. Evaluation of the Effect of Loperamide on the Cardiac Repolarization Interval Using Exposure–Response AnalysisClinical and Translational Science · 2025
11. Design and Evaluation of RNA Aptamer–Mediated Delivery of C/EBP β siRNA for Oncological TherapyJournal of Nucleic Acids · 2025
12. The growth of recovery capital in clients of recovery residences in Florida, USA: a quantitative pilot study of changes in REC-CAP profile scoresSubstance Abuse Treatment Prevention and Policy · 2022
13. The Strengths and Barriers Recovery Scale (SABRS): Relationships Matter in Building Strengths and Overcoming BarriersFrontiers in Psychology · 2021
14. A high affinity human monoclonal antibody against Pfs230 binds multiple parasite stages and blocks oocyst formation in mosquitoes2020
15. Deep sequencing of B cell receptor repertoires from COVID-19 patients reveals strong convergent immune signatures2020
16. Drug testing on arrest–who benefits?Health & Justice · 2020
17. Advances in the Application of Modified Nucleotides in SELEX TechnologyBiochemistry (Moscow) · 2018
18. Support received after bereavement by suicide and other sudden deaths: a cross-sectional UK study of 3432 young bereaved adultsBMJ Open · 2017
19. Translating QT interval prolongation from conscious dogs to humansBritish Journal of Clinical Pharmacology · 2016
20. Stakeholder perceptions and operational barriers in the training and distribution of take-home naloxone within prisons in EnglandHarm Reduction Journal · 2016